Omthera Pharmaceuticals, Inc. (OMTH) is a publicly traded company in the Unknown sector. Across all available filings, 18 corporate insiders have executed 98 transactions totaling $60.0M, demonstrating a bullish sentiment with $60.0M in net insider flow. The most recent transaction on Jul 18, 2013 involved a transaction of 204,308 shares valued at $0.
No significant insider buying has been recorded for OMTH in the recent period.
No significant insider selling has been recorded for OMTH in the recent period.
Based on recent SEC filings, insider sentiment for OMTH is bullish with an Insider Alignment Score of 100/100 and a net flow of $60.0M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at Omthera Pharmaceuticals, Inc. (OMTH) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 18 insiders are actively trading OMTH stock, having executed 98 transactions in the past 90 days. The most active insider is Partners Sas Sofinnova (Executive), who has made 6 transactions totaling $10.1M.
Get notified when executives and directors at OMTH file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Jul 18, 2013 | F. Horner George III | Executive | Disposition | 204,308 | $N/A | $0 | |
| Jul 18, 2013 | Wisler Gerald | Executive | Disposition | 26,382 | $N/A | $0 | |
| Jul 18, 2013 | Wisler Gerald | Executive | Disposition | 661,546 | $N/A | $0 | |
| Jul 18, 2013 | Wisler Gerald | Executive | Disposition | 331,963 | $N/A | $0 | |
| Jul 18, 2013 | Wisler Gerald | Executive | Disposition | 331,963 | $N/A | $0 | |
| Jul 18, 2013 | Wisler Gerald | Executive | Disposition | 26,382 | $N/A | $0 | |
| Jul 18, 2013 | Sas Sofinnova Partners | Executive | Disposition | 7,159,317 | $N/A | $0 | |
| Jul 18, 2013 | Seghezzi Graziano | Executive | Disposition | 0 | $N/A | $0 | |
| Jul 18, 2013 | H. Davidson Michael | Executive | Disposition | 520,756 | $N/A | $0 | |
| Jul 18, 2013 | H. Davidson Michael | Executive | Disposition | 964,587 | $N/A | $0 | |
| Jul 18, 2013 | S. Schade Christian | Executive | Disposition | 341,893 | $N/A | $0 | |
| Jul 18, 2013 | N. M. Machielse Bernardus | Executive | Disposition | 247,005 | $N/A | $0 | |
| Jul 18, 2013 | Associates 13 Lp New Enterprise | Executive | Disposition | 5,833,213 | $N/A | $0 | |
| Jul 18, 2013 | R. Weller Harry | Executive | Disposition | 5,833,213 | $N/A | $0 | |
| Jul 18, 2013 | Viswanathan Ravi | Executive | Disposition | 5,833,213 | $N/A | $0 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Conversion(C) | 45 | $60.9M | 49.9% |
Purchase(P) | 13 | $60.0M | 49.1% |
Exercise(M) | 3 | $1.2M | 1.0% |
Sale(S) | 14 | $18.8K | 0.0% |
Disposition(D) | 23 | $0 | 0.0% |
Insiders at Omthera Pharmaceuticals, Inc. are accumulating shares at an accelerated pace. With 18 insiders making 98 transactions totaling $60.0M in purchases versus $18.8K in sales, the net buying activity of $60.0M signals strong executive confidence. Partners Sas Sofinnova (Executive) leads the buying activity with $10.1M in transactions across all time.